Results 271 to 280 of about 122,604 (290)

Tamoxifen

Reactions Weekly, 2014
openaire   +2 more sources

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen

Annals of Oncology, 2010
Emma Hall, Raoul Charles Coombes, G Bertelli   +2 more
exaly  

Clinical and biomarker predictors of side effects from tamoxifen

Breast Cancer Research and Treatment, 2011
Hope Rugo, Karla Kerlikowske, Elad Ziv   +2 more
exaly  

MANY WOMEN QUIT TAMOXIFEN PREMATURELY

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Tamoxifen

Reactions Weekly, 2017
openaire   +2 more sources

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Tamoxifen methiodide may improve on tamoxifen

Inpharma Weekly, 1996
openaire   +1 more source

Tamoxifen Infrequently Used by Women at Risk for Breast Cancer

Ca-A Cancer Journal for Clinicians, 2010
exaly  

Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin

Archives of Pharmacal Research, 2008
Keon Wook Kang, Jun-Shik Choi
exaly  

Endometriosis developing during tamoxifen therapy

American Journal of Obstetrics and Gynecology, 1988
Michael Turner
exaly